Correlation of ovarian cancer SLC11A2 mRNA with FIGO stage, ethnicity, TP53 mutation status, age, and grade of pathological differentiation (Fig. 3e–i) showed that: SLC11A2 was only significantly different in ethnicity, Asian ovarian cancer Patients had low SLC11A2 mRNA expression. This evidence concerns the gene TP53 and ovarian carcinoma.